ArticlePharmaceuticals (Basel, Switzerland)2023

Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells.

Amirfarbod Yazdanyar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.